Related references
Note: Only part of the references are listed.Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
Maria S. Garcia-Gutierrez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Brain Cannabinoid CB2 Receptor in Schizophrenia
Hiroki Ishiguro et al.
BIOLOGICAL PSYCHIATRY (2010)
CB2: a cannabinoid receptor with an identity crisis
Brady K. Atwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
M. S. Garcia-Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Constitutive Genetic Deletion of the Growth Regulator Nogo-A Induces Schizophrenia-Related Endophenotypes
Roman Willi et al.
JOURNAL OF NEUROSCIENCE (2010)
Serotonin Modulates Fast-Spiking Interneuron and Synchronous Activity in the Rat Prefrontal Cortex through 5-HT1A and 5-HT2A Receptors
M. Victoria Puig et al.
JOURNAL OF NEUROSCIENCE (2010)
Motor Behavior Abnormalities in Drug-Naive Patients with Schizophrenia Spectrum Disorders
Victor Peralta et al.
MOVEMENT DISORDERS (2010)
Modulation of prepulse inhibition through both M1 and M4 muscarinic receptors in mice
Morgane Thomsen et al.
PSYCHOPHARMACOLOGY (2010)
Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice
David Delotterie et al.
PSYCHOPHARMACOLOGY (2010)
Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia
Taro Kishi et al.
PSYCHOPHARMACOLOGY (2010)
A Reverse-Translational Study of Dysfunctional Exploration in Psychiatric Disorders From Mice to Men
William Perry et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Mutant models for genes associated with schizophrenia
Lieve Desbonnet et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level
Elisabeth Barbier et al.
BMC NEUROSCIENCE (2009)
Further pharmacological characterization of 5-HT2C receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo
P. Queree et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Cannabis use and age of diagnosis of schizophrenia
Gisela Sugranyes et al.
EUROPEAN PSYCHIATRY (2009)
Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia
T. B. Halene et al.
GENES BRAIN AND BEHAVIOR (2009)
Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation
Laura Gray et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Prepulse inhibition of the startle response with chronic schizophrenia: A replication study
Masatsugu Moriwaki et al.
NEUROSCIENCE RESEARCH (2009)
Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
Leyre Uriguen et al.
PSYCHOPHARMACOLOGY (2009)
The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone
Isabel Martinez-Gras et al.
SCHIZOPHRENIA RESEARCH (2009)
Behavioral Abnormalities in Synapsin II Knockout Mice Implicate a Causal Factor in Schizophrenia
Bailee A. Dyck et al.
SYNAPSE (2009)
Phenotypic Characterization of Mice Heterozygous for a Null Mutation of Glutamate Carboxypeptidase II
Liqun Han et al.
SYNAPSE (2009)
Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice
Koichi Tanda et al.
MOLECULAR BRAIN (2009)
Behavioral Effects of CB2 Cannabinoid Receptor Activation and Its Influence on Food and Alcohol Consumption
E. S. Onaivi et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice
Susan B. Powell et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions
Maria T. G. Perona et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia
Satoko Hattori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Mechanisms of control of neuron survival by the endocannabinoid system
Ismael Galve-Roperh et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants
Nobutaka Sakae et al.
HUMAN MOLECULAR GENETICS (2008)
Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia
Masashi Ikeda et al.
HUMAN MOLECULAR GENETICS (2008)
Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain
Ildiko Racz et al.
JOURNAL OF NEUROSCIENCE (2008)
A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner
Maria Beatriz Goncalves et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
Istvan Katona et al.
NATURE MEDICINE (2008)
THE STOP NULL MICE MODEL FOR SCHIZOPHRENIA DISPLAYS COGNITIVE AND SOCIAL DEFICITS PARTLY ALLEVIATED BY NEUROLEPTICS
M. Begou et al.
NEUROSCIENCE (2008)
A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition
Mirna Kvajo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories
S. N. Iyer et al.
PSYCHOLOGICAL MEDICINE (2008)
Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders
Nobuyuki Yamasaki et al.
Molecular Brain (2008)
Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors
L. M. Wiedholz et al.
MOLECULAR PSYCHIATRY (2008)
Evidence of disrupted prepulse inhibition in unaffected siblings of bipolar disorder patients
Stella G. Giakournaki et al.
BIOLOGICAL PSYCHIATRY (2007)
Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans
H. Ishiguro et al.
PHARMACOGENOMICS JOURNAL (2007)
Nogo Receptor 1 (RTN4R) as a Candidate Gene for Schizophrenia: Analysis Using Human and Mouse Genetic Approaches
Ruby Hsu et al.
PLOS ONE (2007)
The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia
T. D. Wolinsky et al.
GENES BRAIN AND BEHAVIOR (2007)
Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia
T. Karl et al.
GENES BRAIN AND BEHAVIOR (2007)
Adult mice with reduced Nurr1 expression:: an animal model for schizophrenia
P. Rojas et al.
MOLECULAR PSYCHIATRY (2007)
Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice
Elisabeth Barbier et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Substance use in a population-based clinic sample of people with first-episode psychosis
Jennifer H. Barnett et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
The emerging functions of endocannabinoid signaling during CNS development
Tibor Harkany et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: A double-blind, randomized controlled trial
Jonathan K. Wynn et al.
SCHIZOPHRENIA RESEARCH (2007)
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
Javier Fernandez-Ruiz et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
Javier Palazuelos et al.
FASEB JOURNAL (2006)
Olanzapine differentially affects 5-HT2A and 2C receptor mRNA expression in the rat brain
Xu-Feng Huang et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Antipsychotics improve Δ9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice
Hiroshi Nagai et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
Disruption of the prepulse inhibition of the startle reflex in vasopressin VLb receptor knockout mice: Reversal by antipsychotic drugs
N Egashira et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Behavioral and neurochemical phenotyping of Homer1 mutant mice:: possible relevance to schizophrenia
KK Szumlinski et al.
GENES BRAIN AND BEHAVIOR (2005)
The neurodevelopmental model of schizophrenia: update 2005
JL Rapoport et al.
MOLECULAR PSYCHIATRY (2005)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies
A Abi-Dargham et al.
EUROPEAN PSYCHIATRY (2005)
Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors
L Urigüen et al.
NEUROPHARMACOLOGY (2004)
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
A Giuffrida et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study
S Zammit et al.
BRITISH MEDICAL JOURNAL (2002)
Cannabis and schizophrenia:: impact on onset, course, psychopathology and outcomes
G Bersani et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2002)
Involvement of CB1 cannabinoid receptors in emotional behaviour
M Martin et al.
PSYCHOPHARMACOLOGY (2002)
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies
DL Braff et al.
PSYCHOPHARMACOLOGY (2001)
Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
B Dean et al.
NEUROSCIENCE (2001)
Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods
TD Schmittgen et al.
ANALYTICAL BIOCHEMISTRY (2000)
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
NE Buckley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
